Crispr Therapeutics shares owned by Rafferty Asset Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Rafferty Asset Management
from 13F filings
Historical chart of Rafferty Asset Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Rafferty Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Rafferty Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $10M | 214k | 46.98 |
| 2024-03-31 | $8.4M | 124k | 68.16 |
| 2023-09-30 | $8.6M | 189k | 45.39 |
| 2023-06-30 | $8.2M | 147k | 56.14 |
| 2023-03-31 | $7.1M | 157k | 45.23 |
| 2022-12-31 | $6.7M | 165k | 40.65 |
| 2022-09-30 | $6.8M | 103k | 65.35 |
| 2022-06-30 | $3.6M | 60k | 60.77 |
| 2022-03-31 | $1.6M | 26k | 62.76 |
| 2021-12-31 | $2.2M | 29k | 75.79 |
| 2021-09-30 | $3.2M | 29k | 111.92 |
| 2021-06-30 | $5.1M | 32k | 161.90 |